RON and DEK are implicated in breast cancer metastasis and recurrence, and since these same phenotypes have been linked to lipid dysregulation, the gene signature discovered here might have diagnostic and prognostic potential for patients with breast and other cancer types. This evidence concerns the gene DEK and breast cancer.